An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA

被引：0
|
作者：
Arielle G. Bensimon
Zheng-Yi Zhou
Madeline Jenkins
Yan Song
Wei Gao
James Signorovitch
Clemens Krepler
Emilie Scherrer
Jingshu Wang
Raquel Aguiar-Ibáñez
机构：
[1] Analysis Group,
[2] Inc.,undefined
[3] Analysis Group,undefined
[4] Inc.,undefined
[5] Merck & Co.,undefined
[6] Inc.,undefined
[7] Merck Sharp & Dohme BV,undefined
来源：
Clinical Drug Investigation | 2020年 / 40卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：629 / 643
页数：14
相关论文
共 50 条
  • [1] An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
    Bensimon, Arielle G.
    Zhou, Zheng-Yi
    Jenkins, Madeline
    Song, Yan
    Gao, Wei
    Signorovitch, James
    Krepler, Clemens
    Scherrer, Emilie
    Wang, Jingshu
    Aguiar-Ibanez, Raquel
    [J]. CLINICAL DRUG INVESTIGATION, 2020, 40 (07) : 629 - 643
  • [2] Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
    Bensimon, Arielle G.
    Zhou, Zheng-Yi
    Jenkins, Madeline
    Song, Yan
    Gao, Wei
    Signorovitch, James
    Krepler, Clemens
    Liu, Frank Xiaoqing
    Wang, Jingshu
    Aguiar-Ibanez, Raquel
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (10) : 981 - 993
  • [3] Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
    Eggermont, Alexander M. M.
    Blank, Christian U.
    Mandala, Mario
    Long, Georgina, V
    Atkinson, Victoria
    Dalle, Stephane
    Haydon, Andrew
    Lichinitser, Mikhail
    Khattak, Adnan
    Carlino, Matteo S.
    Sandhu, Shahneen
    Larkin, James
    Puig, Susana
    Ascierto, Paolo A.
    Rutkowski, Piotr
    Schadendorf, Dirk
    Koornstra, Rutger
    Hernandez-Aya, Leonel
    Maio, Michele
    van den Eertwegh, Alfonsus J. M.
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Jamal, Rahima
    Lorigan, Paul
    Ibrahim, Nageatte
    Marreaud, Sandrine
    van Akkooi, Alexander C. J.
    Suciu, Stefan
    Robert, Caroline
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19): : 1789 - 1801
  • [4] Adjuvant Pembrolizumab in Resected Stage III Melanoma
    Barker, Christopher A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 593 - 593
  • [5] KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma
    Luke, Jason J.
    Ascierto, Paolo A.
    Carlino, Matteo S.
    Gershenwald, Jeffrey E.
    Grob, Jean-Jacques
    Hauschild, Axel
    Kirkwood, John M.
    Long, Georgina, V
    Mohr, Peter
    Robert, Caroline
    Ross, Merrick
    Scolyer, Richard A.
    Yoon, Charles H.
    Poklepovic, Andrew
    Rutkowski, Piotr
    Anderson, James R.
    Ahsan, Sama
    Ibrahim, Nageatte
    Eggermont, Alexander M. M.
    [J]. FUTURE ONCOLOGY, 2020, 16 (03) : 4429 - 4438
  • [6] Phase III KEYNOTE-716 study: Adjuvant therapy with pembrolizumab versus placebo in resected high-risk stage II melanoma.
    Luke, Jason J.
    Ascierto, Paolo Antonio
    Carlino, Matteo S.
    Eggermont, Alexander M. M.
    Grob, Jean-Jacques
    Hauschild, Axel
    Kirkwood, John M.
    Long, Georgina V.
    Mohr, Peter
    Robert, Caroline
    Gershenwald, Jeffrey E.
    Poklepovic, Andrew Stewart
    Ross, Merrick I.
    Scolyer, Richard A.
    Yoon, Charles
    Anderson, James R.
    Ahsan, Sama
    Ibrahim, Nageatte
    Sondak, Vernon K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [7] Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
    Grossmann, Kenneth F.
    Othus, Megan
    Patel, Sapna P.
    Tarhini, Ahmad A.
    Sondak, Vernon K.
    Knopp, Michael, V
    Petrella, Teresa M.
    Truong, Thach-Giao
    Khushalani, Nikhil, I
    Cohen, Justine, V
    Buchbinder, Elizabeth, I
    Kendra, Kari
    Funchain, Pauline
    Lewis, Karl D.
    Conry, Robert M.
    Chmielowski, Bartosz
    Kudchadkar, Ragini R.
    Johnson, Douglas B.
    Li, Hongli
    Moon, James
    Eroglu, Zeynep
    Gastman, Brian
    Kovacsovics-Bankowski, Magdalena
    Gunturu, Krishna S.
    Ebbinghaus, Scot W.
    Ahsan, Sama
    Ibrahim, Nageatte
    Sharon, Elad
    Korde, Larissa A.
    Kirkwood, John M.
    Ribas, Antoni
    [J]. CANCER DISCOVERY, 2022, 12 (03) : 644 - 653
  • [8] The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies
    Kibel, Seth
    Kuehne, Nathan
    Ribeiro, Mauricio Fernando
    Muniz, Thiago P.
    Ye, Xiang Y.
    Spreafico, Anna
    Saibil, Samuel D.
    Sun, Alexander
    Mak, David Y.
    Gray, Diana
    Jones, Bailie
    Wong, Philip
    Butler, Marcus O.
    [J]. CANCERS, 2023, 15 (24)
  • [9] Adjuvant therapy for resected high-risk melanoma
    Moser, Justin C.
    Grossmann, Kenneth F.
    [J]. SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (02) : 109 - 111
  • [10] Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
    Kaufmann, Fabrice
    Goldinger, Simone M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 15 - 16
12345